Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01725945 · ClinicalTrials.gov registry record · NA
The DASH Diet for Adults With Uncontrolled Asthma
A NA study, sponsored by Palo Alto Medical Foundation.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01725945: Completed NA study, sponsored by Palo Alto Medical Foundation.
NCT01725945 is a NA study that has completed, run by Palo Alto Medical Foundation. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01725945, a NA study, has completed, sponsored by Palo Alto Medical Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
Dietary intervention efficacy trials are distinctly lacking in asthma research. This pilot study aims to provide effect size estimates and justification, clinical trial and intervention feasibility data, and procedural materials for a full-scale randomized controlled trial that will determine the efficacy and mechanisms of action of the Dietary Approaches to Stop Hypertension (DASH)-a recommended dietary pattern based on proven cardiovascular benefits-as adjunct therapy to standard care for adults with uncontrolled asthma.
Primary Outcome
The ACQ provides a reliable, validated assessment of asthma control focusing on current impairment. Its 7 items assess the components of current asthma impairment as defined in the asthma treatment guidelines, i.e., daytime and nocturnal asthma symptoms, activity limitations, rescue medication use (excluding use to prevent exercise-induced bronchospasm), and lung function (FEV1). The ACQ is the only guideline-recommended composite measure of asthma control that includes lung function in its over
Interventions
- BEHAVIORAL Dietary Approaches to Stop Hypertension dietary pattern
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT01725945 record still lists
NCT01725945 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Dietary Approaches to Stop Hypertension dietary pattern is the first listed.
NCT01725945 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01725945 about?
NCT01725945 is a clinical study titled "The DASH Diet for Adults With Uncontrolled Asthma". Dietary intervention efficacy trials are distinctly lacking in asthma research. This pilot study aims to provide effect size estimates and justification, clinical trial and intervention feasibility data, and procedural materials for a full-scale randomized controlled trial that will determine the ef...
What is the current status of trial NCT01725945?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2013-01. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01725945?
The interventions under investigation include: Dietary Approaches to Stop Hypertension dietary pattern (BEHAVIORAL).
Who is sponsoring clinical trial NCT01725945?
This trial is sponsored by Palo Alto Medical Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01725945's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia